Eliciting health state utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiency: a UK vignette study

被引:5
|
作者
Smith, Adam B. [1 ]
Hanbury, Andria [1 ]
Buesch, Katharina [2 ]
机构
[1] Univ York, York Hlth Econ Consortium Ltd, Enterprise House,Innovat Way, York YO10 5NQ, N Yorkshire, England
[2] PTC Therapeut Inc, 100 Corp Court, South Plainfield, NJ 07080 USA
关键词
AADC deficiency; Vignettes; Time trade-off; Standard gamble; QUALITY-OF-LIFE; TIME TRADE-OFF; STANDARD GAMBLE; RATING-SCALE;
D O I
10.1186/s41687-021-00403-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose The aim of this study was to generate health state utilities for aromatic L-amino acid decarboxylase (AADC) deficiency, a rare genetic, lifelong neurogenerative condition predominantly manifesting in young infants. Methods Participants were presented with health state vignettes. These had been previously developed based on published literature, clinician input, interviews with parents of AADC deficiency patients and expert opinion. A total of 5 health state vignettes were presented: bedridden, head control, sitting unsupported, standing with assistance and walking with assistance. Health state utilities (HSU) were elicited using time-trade off (TTO; 10-year time horizon) and the standard gamble (SG). The vignettes were completed online by panel participants drawn from a representative sample of the United Kingdom residential population. Results A total of 1598 participants completed the vignettes. Around 21% had incongruent responses (higher utilities for the bedridden compared to walking health states). Incongruent responses were associated with shorter task completion times, gender and parental status. These responses were removed from the analysis. Health state utilities (HSU) increased correspondingly as health states improved for both the TTO and SG. The mean HSU (standard deviation) for the TTO task were: bedridden state 0.49 (0.34); head control 0.54 (0.33), sitting unsupported 0.63 (0.31); standing with assistance 0.68 (0.31); and walking with assistance 0.73 (0.31). For the SG, mean health state utilities were: 0.56 (0.28), 0.57 (0.27), 0.67 (0.24), 0.70 (0.24), and 0.75 (0.25), respectively. Conclusion Health state utilities were derived for AADC deficiency through a vignette study. These will be used for a cost-effectiveness model of an AADC deficiency treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Eliciting health state utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiency: a UK vignette study
    Adam B. Smith
    Andria Hanbury
    Katharina Buesch
    Journal of Patient-Reported Outcomes, 5
  • [2] Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France
    Smith, Adam B.
    Hanbury, Andria
    de Zarate, Igor Beitia Ortiz
    Hammes, Florence
    de Pouvourville, Gerard
    Buesch, Katharina
    PATIENT-RELATED OUTCOME MEASURES, 2021, 12 : 237 - 246
  • [3] A VIGNETTE STUDY TO DERIVE HEALTH STATE UTILITIES FOR AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY IN THE UNITED KINGDOM (UK)
    Smith, A.
    Hanbury, A.
    Buesch, K.
    VALUE IN HEALTH, 2020, 23 : S712 - S713
  • [4] A DISCRETE CHOICE EXPERIMENT TO DERIVE HEALTH STATE UTILITIES FOR AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY IN FRANCE
    Smith, A.
    Hanbury, A.
    Whitty, J.
    Beitia, Ortiz de Zarate, I
    Hammes, F.
    De Pouvourville, G.
    Buesch, K.
    VALUE IN HEALTH, 2021, 24 : S206 - S206
  • [5] AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY IN UK: BURDEN OF DISEASE
    Boehnke, A.
    Balman, E.
    Davidson, I
    Hobdell, K.
    Rance, M.
    Buesch, K.
    VALUE IN HEALTH, 2022, 25 (01) : S263 - S263
  • [6] A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Smith, Adam B.
    Hanbury, Andria
    Whitty, Jennifer A.
    Buesch, Katharina
    PATIENT-RELATED OUTCOME MEASURES, 2021, 12 : 97 - 106
  • [7] A DISCRETE CHOICE EXPERIMENT TO DERIVE HEALTH STATE UTILITIES FOR AROMATIC L-AMINO ACID DECARBOXYLASE (AADC) DEFICIENCY IN THE UNITED KINGDOM
    Smith, A.
    Hanbury, A.
    Whitty, J.
    Buesch, K.
    VALUE IN HEALTH, 2020, 23 : S714 - S714
  • [8] A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France
    Smith, Adam B.
    Hanbury, Andria
    Whitty, Jennifer A.
    de Zarate, Igor Beitia Ortiz
    Hammes, Florence
    de Pouvourville, Gerard
    Buesch, Katharina
    PATIENT-RELATED OUTCOME MEASURES, 2022, 13 : 21 - 30
  • [9] A Murine Model of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Hwu, Wuh-Liang
    Lee, Ni-Chung
    Hsieh, Yi-Da
    Lin, Shu-Wha
    Chien, Yin-Hsiu
    MOLECULAR THERAPY, 2012, 20 : S58 - S58
  • [10] A review of aromatic l-amino acid decarboxylase (AADC) deficiency in Taiwan
    Lee, Ni-Chung
    Chien, Yin-Hsiu
    Hwu, Wuh-Liang
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2019, 181 (02) : 226 - 229